The identification of the IL-23 receptor (IL-23R) as a susceptibility locus for IBD and the clinical utility of anti-IL-23 antibodies confirm IL-23′s involvement in the pathophysiology of UC [81,82]. The gene discussed is IL23A; the disease is inflammatory bowel disease.